Failure to Monitor Long-Term Antibiotic Therapy
Summary
The facility failed to implement its antibiotic stewardship program for two residents who were receiving long-term antibiotic therapy. Resident 39 was admitted and later readmitted with diagnoses including chronic respiratory failure, acute tracheitis, and gastrostomy, and was described as delayed, spastic with upper extremity flexion contractures, non-verbal, and dependent for mobility and ADLs. The resident had an order for Erythromycin Ethyl succinate 70 mg via g-tube every 6 hours for delayed gastric emptying and gastric motility for 6 months, and the care plan identified the resident as at risk for adverse effects due to long-term antibiotic therapy. During interview and record review, RN 2 stated there was no physician order to monitor for adverse effects from Erythromycin Ethyl succinate and that progress notes and nursing assessments from 12/2025 to 1/2026 did not show specific monitoring for antibiotic adverse effects. RN 2 stated that documenting no change in condition meant the antibiotic effects were monitored, and that it was acceptable to be vague in documenting monitoring. RN 9 stated staff should verify the indication, end date, and specified adverse-effect monitoring when antibiotics are administered, and that the licensed nurse receiving the order should clarify with the physician what adverse effects to monitor. The MP, DON, and IP all stated that staff should monitor and document specific adverse effects of antibiotics, including when used prophylactically, and that the lack of specific monitoring could contribute to antibiotic resistance. Resident 71 was admitted and later readmitted with diagnoses including acute upper respiratory tract infection, gastrostomy, and otitis media, and was described as well nourished, in no acute distress, non-verbal, with spasticity, hypertonicity, and clonus bilaterally. The resident had severely impaired cognition and an order for Metronidazole 187 mg via g-tube every 8 hours for ethylmalonic encephalopathy for 6 months, with a care plan intervention to assess for signs and symptoms of adverse reactions and report to the MD. RN 2 again stated there was no physician order to monitor for adverse effects and that the charting did not show specific monitoring, while RN 9, the MP, the DON, and the IP stated that antibiotic therapy required specific adverse-effect monitoring and documentation. The facility’s antibiotic stewardship policy and the pharmacist job description both referenced reducing unnecessary antibiotic use and identifying medications requiring special study based on adverse drug reactions, but the records reviewed for these two residents did not show the required specific monitoring for adverse effects.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release July 29, 2026) and official state health department websites — never guesswork.
In your survey window? See what surveyors are citing.
The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.